RARE
$14.54-4.15%
Ultragenyx Pharmaceutical Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.007%US Stock Market 0.004%Russell 3000 0.004%
Ultragenyx Pharmaceutical Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Ultragenyx Pharmaceutical Inc. total returns by year (2015–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $23.00 | $14.54 | 0.0% | -36.8% | |
| 2025 | $42.07 | $23.00 | 0.0% | -45.3% | |
| 2024 | $47.82 | $42.07 | 0.0% | -12.0% | |
| 2023 | $46.33 | $47.82 | 0.0% | +3.2% | |
| 2022 | $84.09 | $46.33 | 0.0% | -44.9% | |
| 2021 | $138.43 | $84.09 | 0.0% | -39.3% | |
| 2020 | $42.71 | $138.43 | 0.0% | +224.1% | |
| 2019 | $43.48 | $42.71 | 0.0% | -1.8% | |
| 2018 | $46.38 | $43.48 | 0.0% | -6.3% | |
| 2017 | $70.31 | $46.38 | 0.0% | -34.0% | |
| 2016 | $112.18 | $70.31 | 0.0% | -37.3% | |
| 2015 | $43.88 | $112.18 | 0.0% | +155.7% |
- Annualized
- -8.1%
- 2015–2026
- Average year
- +14.7%
- 11 full years
- Best year
- +224.1%
- 2020
- Worst year
- -45.3%
- 2025
- Positive years
- 3/11
- 27% up
Annualized (CAGR)
-8.1%
2015–2026
Average year
+14.7%
11 full years
Best year
+224.1%
2020
Worst year
-45.3%
2025
Positive years
3/11
27% up
Total return by period#
Annual
-200%-100%0%100%200%
2015+156%'15
2016-37%'16
2017-34%'17
2018-6.3%'18
2019-1.8%'19
2020+224%'20
2021-39%'21
2022-45%'22
2023+3.2%'23
2024-12%'24
2025-45%'25
2026-37%'26
Methodology#
Total returns, dividends reinvested, measured on RARE. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Ultragenyx Pharmaceutical Inc.'s average annual return?
- Since 2015, Ultragenyx Pharmaceutical Inc. (RARE) has returned about -8.1% a year (the compound annual growth rate) and an average calendar-year return of 14.7%.
- What were Ultragenyx Pharmaceutical Inc.'s best and worst years?
- Over 2015–2026, the best year was 2020 (+224.1%) and the worst was 2025 (-45.3%).
- How often is Ultragenyx Pharmaceutical Inc. up in a year?
- 3 of the 11 full years since 2015 were positive — about 27% of the time.
More on Ultragenyx Pharmaceutical Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100